Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Financial support: The Linkermann group is funded by the German research foundation in the Cluster of Excellence, Inflammation at interfaces (EXC 306), and the research is supported by Genentech, Glaxo Smith Kline, and Apogenix (material transfer agreements).
☆☆Conflict of interest statement: The author has received research grants from Pfizer, Novartis, Fresenius Medical Care, and the Else Kröner-Fresenius Stiftung, and honoraria and/or travel grants from Astellas, Otsuka, Genentech, Alexion, and Tekmira.